Clinical Trial Update: Efficacy and Safety of Imatinib Mesylate as First-line Treatment for the Patients With Chronic Phase of Chronic Myeloid Leukemia [Phase 4]

View source ↗

Summary

This document provides an update on a Phase 4 trial evaluating the efficacy and safety of imatinib mesylate as first-line treatment for patients with chronic ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: Cttq | Conditions: Chronic Myeloid Leukemia | Phase 4 | Status: UNKNOWN